These results demonstrated that the inhibition of PAR1 but not PAR2 could reverse the improved proliferative and metastatic potential, including migration and invasion, of CRC cells induced by KLK8 overexpression. The gene discussed is F2RL1; the disease is colorectal carcinoma.